Market Research Logo

Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Bio

Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users), and Geography

The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.

The growth of the oligonucleotide synthesis market is primarily attributed to the increasing applications of synthesized oligonucleotides, increasing investments for synthetic biology, technological advancements genome editing tools are boosting the market over the years. However, renewed regulations for biotechnology and lack of skilled professionals in life science industry are likely to pose a negative impact on the market growth. On the other hand, advancements in synthetic biology is likely to have a positive impact on the growth of the global oligonucleotide synthesis market in the coming years. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. There is hardly a field in biology in which synthetic DNA has not been used or does not have the potential to be used. Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. Oligonucleotide probes are used to detect single base pair changes within human genome. For instance, sickle cell anemia which is caused by a transversion (A^T) within β-globin gene can be analyzed with labeled oligonucleotides. The increasing applications of synthesized oligonucleotides is likely to foster the growth of market in the coming years.

Global oligonucleotide synthesis market, based on product was segmented into synthesized oligonucleotides, reagents, and equipment. In 2018, the synthesized oligonucleotides segment held a largest market share of 48.3% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.

Global oligonucleotide synthesis market, based on application was segmented into research, diagnostics, and therapeutics. Research segment is anticipated to grow at a CAGR of 45.3% during the forecast period. The availability of funds as well as supportive government policies are expected to boost the growth of the segment during the forecast period. The segment is also expected to retain its position among the other applications during the year 2027.

Some of the major primary and secondary sources for oligonucleotide synthesis included in the report are World Health Organization (WHO), National Center for Biotechnology Information (NCBI), Association of the British Pharmaceutical Industry (ABPI), Bio-Industry Association (BIA), Defense Advanced Research Projects Agency (DARPA), Pharmaceutical Research and Manufacturers of America (PhRMA), Food & Drug Administration (FDA), International Federation of Pharmaceutical Manufacturers & Associations and others.


1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Oligonucleotide Synthesis Market - By Product
1.3.2 Global Oligonucleotide Synthesis Market - By Application
1.3.3 Global Oligonucleotide Synthesis Market - By End User
1.3.4 Global Oligonucleotide synthesis Market - By Geography
2. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 KEY MARKET DRIVERS
4.3.1 Increasing Applications of Synthesized Oligonucleotides
4.3.2 Increasing Investments for Synthetic Biology
4.3.3 Technological Advancements Genome Editing Tools
4.4 KEY MARKET RESTRAINTS
4.4.1 Renewed Regulations for Biotechnology
4.4.2 Lack Of Skilled Professionals In Life Science Industry
4.5 KEY MARKET OPPORTUNITIES
4.5.1 Collaborations - The Future of Innovation
4.6 FUTURE TRENDS
4.6.1 Advancements in Synthetic Biology
4.7 IMPACT ANALYSIS
5. OLIGONUCLEOTIDE SYNTHESIS MARKET - GLOBAL ANALYSIS
5.1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 GenScript
5.4 EXPERT OPINIONS
6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS - BY PRODUCT
6.1 OVERVIEW
6.2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2018 & 2027 (%)
6.3 SYNTHESIZED OLIGONUCLEOTIDES MARKET
6.3.1 Overview
6.3.2 Global Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.3 Primers Market
6.3.3.1 Overview
6.3.3.2 Global Primers Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4 Probes Market
6.3.4.1 Overview
6.3.4.1.1 Global Probes Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.2 Large-Scale Synthesis Oligonucleotides Market
6.3.4.2.1 Overview
6.3.4.2.2 Global Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.3 Others Market
6.3.4.3.1 Overview
6.3.4.3.2 Global Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 REAGENTS MARKET
6.4.1 Overview
6.4.2 Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 EQUIPMENT MARKET
6.5.1 Overview
6.5.2 Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS - BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2018 & 2027 (%)
7.3 RESEARCH MARKET
7.3.1 Overview
7.3.2 Global Research Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 DIAGNOSTICS MARKET
7.4.1 Overview
7.4.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 THERAPEUTICS MARKET
7.5.1 Overview
7.5.2 Global Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS - BY END USER
8.1 OVERVIEW
8.2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2018 & 2027 (%)
8.3 ACADEMIC RESEARCH INSTITUTES MARKET
8.3.1 Overview
8.3.2 Global Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 DIAGNOSTIC LABORATORIES MARKET
8.4.1 Overview
8.4.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
8.5.1 Overview
8.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 OTHER END USERS MARKET
8.6.1 Overview
8.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
9. OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHY ANALYSIS
9.1 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027
9.1.1 North America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.2.1 North America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.2.1 US Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.2.1 Canada Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.2.1 Mexico Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027
9.2.1 Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.2.1 Europe Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.3 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.4 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.5 Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.2.6 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.6.2.1 UK Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.6.3 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.6.4 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.7 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.7.2.1 Germany Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.7.3 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.7.4 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.8 France Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.8.2.1 France Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.8.3 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.8.4 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.9 Italy Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.2 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.9.2.1 Italy Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.9.3 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.9.4 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.10 Spain Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.1 Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.2 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.10.2.1 Spain Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.10.3 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.10.4 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3 ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027
9.3.1 Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.2 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.2.1 Asia Pacific Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.3 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.4 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.5 Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.3.6 China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.1 China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.6.2.1 China Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.6.3 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.6.4 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.7 India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.2 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.7.2.1 India Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.7.3 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.7.4 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.8 Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.1 Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.2 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.8.2.1 Japan Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.8.3 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.8.4 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.9 Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.2 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.9.2.1 Australia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.9.3 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.9.4 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.10 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.1 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.2 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.10.2.1 South Korea Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.10.3 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.10.4 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027
9.4.1 Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.2 Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.2.1 Middle East & Africa Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.3 Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.4 Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.5 Middle East & Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.4.6 Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.2 Saudi Arabia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.6.2.1 Saudi Arabia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.6.3 Saudi Arabia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.7 South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.1 South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.2 South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.7.2.1 South Africa Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.7.3 South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.7.4 South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.8 UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.1 UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.2 UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.8.2.1 UAE Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.8.3 UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.8.4 UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5 SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027
9.5.1 South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.2 South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.5.2.1 South and Central America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.3 South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.5.4 South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.5 South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027, By Country (%)
9.5.6 Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.1 Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.2 Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.5.6.2.1 Argentina Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.6.3 Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.5.6.4 Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.7 Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.2 Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.5.7.2.1 Brazil Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.7.3 Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.5.7.4 Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. OLIGONUCLEOTIDE SYNTHESIS MARKET -INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 COMPARATIVE COMPANY ANALYSIS
10.3 GROWTH STRATEGIES DONE BY THE COMPANIES IN THE MARKET, (%)
10.4 ORGANIC DEVELOPMENTS
10.4.1 Overview
10.5 INORGANIC DEVELOPMENTS
10.5.1 Overview
11. OLIGONUCLEOTIDE SYNTHESIS MARKET-KEY COMPANY PROFILES
11.1 THERMO FISHER SCIENTIFIC INC.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GENSCRIPT
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 SYNTHOMICS, INC.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 ANSA BIOTECHNOLOGIES, INC.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 IRIDIA, INC.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 HELIXWORKS
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 KEASLING LAB
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 MOLECULAR ASSEMBLIES
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 TWIST BIOSCIENCE
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 EVONETIX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 DNA SCRIPT
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 NUCLERA NUCLEICS LTD.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 CAMENA BIO
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
LIST OF TABLES
TABLE 1. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 3. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 4. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 5. US OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 6. US SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 7. US OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 8. US OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 9. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 10. CANADA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 11. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 12. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 13. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 14. MEXICO SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 15. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 16. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 17. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 18. EUROPE SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 19. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 20. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 21. UK OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 22. UK SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 23. UK OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 24. UK OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 25. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 26. GERMANY SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 27. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 28. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 29. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 30. FRANCE SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 31. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 32. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 33. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 34. ITALY SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 35. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 36. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 37. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 38. SPAIN SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 39. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 40. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 41. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 42. ASIA PACIFIC SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 43. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 44. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 45. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 46. CHINA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 47. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 48. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 49. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 50. INDIA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 51. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 52. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 53. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 54. JAPAN SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 55. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 56. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 57. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 58. AUSTRALIA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 59. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 60. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 61. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 62. SOUTH KOREA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 63. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 64. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 65. MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 66. MIDDLE EAST & AFRICA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 67. MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 68. MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 69. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 70. SAUDI ARABIA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 71. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 72. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 73. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 74. SOUTH AFRICA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 75. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 76. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 77. UAE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 78. UAE SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 79. UAE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 80. UAE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 81. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 82. SOUTH AND CENTRAL AMERICA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 83. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 84. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 85. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 86. ARGENTINA SYNTHESIZED OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 87. ARGENT

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report